Beur schreef op 16 mei 2016 22:34:
Short seller Left now long ValeantMay 16 2016, 15:41 ET | About: Valeant Pharmaceutical... (VRX) | By: Douglas W. House,
The hot place down under has officially frozen over. Noted bear Andrew Left of Citron Research fame says he is now long Valeant Pharmaceuticals (VRX +4.7%). He says he "wouldn't be surprised if there is a bounce" in the stock considering the prolonged downtrend. He also points out the importance of Xifaxan (rifaximin), acquired in the Salix deal, which the company expects to be a key growth driver as it looks to lighten its debt load.
--------------------------
Opmerkelijk: de man die vorig jaar de knuppel in het hoenderhok gooide, Andy Left , vindt de daling van Valeant nu wel voldoende geweest en gaat nu long.
Valeant +4,47%